SCHEMBL26697038

SCHEMBL26697038

O=[N+]([O-])c1ccc2c(-c3nc(Cl)ncc3Cl)c[nH]c2c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CLK1 P49759 3/20 0.59
▸ CDK5 Q00535 2/20 0.59
▸ CDK5R1 Q15078 2/20 0.59
▸ RPS6KA5 O75582 2/20 0.48
▸ CYP3A4 P08684 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ NOS1 P29475 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ PKM P14618 1/20 0.43
▸ PKLR P30613 1/20 0.43
▸ ELANE P08246 1/20 0.42
▸ NAMPT P43490 1/20 0.41
▸ XDH P47989 1/20 0.41
▸ NPBWR1 P48145 4/20 0.40
▸ OPRK1 P41145 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ MAOB P27338 1/20 0.40
▸ PTPRA P18433 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30716301 1.00 CLK1 (0.59) CLK1CDK5CDK5R1RPS6KA5CYP3A4
SCHEMBL26697091 0.85 CLK1 (0.54) CLK1CDK5CDK5R1CDK2CCNT1
SCHEMBL30716382 0.85 CLK1 (0.54) CLK1CDK5CDK5R1CDK2CCNT1
SCHEMBL21629016 0.81 RPS6KA5 (0.56) CLK1CDK5CDK5R1RPS6KA5CDK2
SCHEMBL30554764 0.81 RPS6KA5 (0.56) CLK1CDK5CDK5R1RPS6KA5CDK2
SCHEMBL20680088 0.79 RPS6KA5 (0.53) CLK1CDK5CDK5R1RPS6KA5KMT2A
SCHEMBL30554773 0.79 RPS6KA5 (0.53) CLK1CDK5CDK5R1RPS6KA5KMT2A
SCHEMBL20680017 0.79 RPS6KA5 (0.53) RPS6KA5CDK2CCNT1CCNKCCNE1
SCHEMBL30554772 0.79 RPS6KA5 (0.53) RPS6KA5CDK2CCNT1CCNKCCNE1
SCHEMBL26696887 0.79 CLK1 (0.57) CLK1CDK5CDK5R1RPS6KA5CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023227125-A1 NEW FUSED-HETEROCYCLIC COMPOUND AS CDK INHIBITOR AND USE THEREOF 杭州德睿智药科技有限公司 2023-11-30 — — WO disclosed
Send feedback